AIM ImmunoTech Inc.
AIM
Price:
$0.4059
Market Cap:
$1.38M
AIM ImmunoTech Inc., an immuno-pharmaceutical company based in Ocala, Florida, focuses on discovering and advancing treatments for a diverse array of cancers, viral infections, and immune system disorders across the United States. Its primary drug offerings include Ampligen (rintatolimod), a large macromolecular double-stranded ribonucleic acid compound developed for chronic fatigue syndrome, and Alferon N Injection (Interferon alfa), a purified, naturally derived, multi-species alpha interferon prescribed for genital warts. Furthermore, Ampligen is currently undergoing investigation for its potential application in treating pancreatic, renal cell, malignant melanoma, non-small cell lung, ov...[Read more]
Industry
Biotechnology
IPO Date
1995-11-02
Stock Exchange
AMEX
Ticker
AIM
PE Ratio
[-0.09]
ROE
[261.84%]
Current Ratio
[1.01]
Dividend Yield
[0%]
Enterprise Value
[139.50K]
Dividend History
The ROE as of June 2026 (TTM) for AIM ImmunoTech Inc. (AIM) is 261.84%
According to AIM ImmunoTech Inc.’s latest financial reports and current stock price. The company's current ROE is 261.84%. This represents a change of -36716.32% compared to the average of -0.72% of the last 4 quarters.
AIM ImmunoTech Inc. (AIM) Historical ROE (quarterly & annually)
How has AIM ROE performed in the past?
The mean historical ROE of AIM ImmunoTech Inc. over the last ten years is 65.63%. The current 261.84% ROE has changed 298.95% with respect to the historical average. Over the past ten years (40 quarters), AIM's ROE was at its highest in in the December 2024 quarter at 451.36%. The ROE was at its lowest in in the March 2026 quarter at -142.26%.
Average
65.63%
Median
-49.48%
Minimum
-283.00%
Maximum
1.31%
AIM ImmunoTech Inc. (AIM) ROE by Quarter and Year
Discovering the peaks and valleys of AIM ImmunoTech Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 459.85%
Maximum Annual ROE = 1.31%
Minimum Annual Increase = -562.95%
Minimum Annual ROE = -283.00%
| Year | ROE | Change |
|---|---|---|
| 2025 | 142.68% | -89.11% |
| 2024 | 1.31% | -562.95% |
| 2023 | -283.00% | 459.85% |
| 2022 | -50.55% | 50.32% |
| 2021 | -33.63% | 43.14% |
| 2020 | -23.49% | -67.76% |
| 2019 | -72.86% | -61.58% |
| 2018 | -189.66% | 99.86% |
| 2017 | -94.90% | 96.05% |
| 2016 | -48.41% | -35.25% |
AIM ImmunoTech Inc. (AIM) Average ROE
How has AIM ROE performed in the past?
The current ROE of AIM ImmunoTech Inc. (AIM) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
389.94%
5-year avg
217.13%
10-year avg
65.63%
AIM ImmunoTech Inc. (AIM) ROE vs. Peers
How is AIM’s ROE compared to its peers?
AIM ImmunoTech Inc.’s ROE is greater than KALA BIO, Inc. (-1335.64%), greater than Oragenics, Inc. (-177.32%), greater than Pasithea Therapeutics Corp. (-57.44%), greater than VYNE Therapeutics Inc. (-69.57%), greater than Quoin Pharmaceuticals, Ltd. (-292.33%), greater than Ensysce Biosciences, Inc. (-631.47%), greater than XTL Biopharmaceuticals Ltd. (-26.83%), greater than Alaunos Therapeutics, Inc. (-165.94%), greater than Can-Fite BioPharma Ltd. (-141.01%), greater than Soligenix, Inc. (-246.04%),
| Company | ROE | Market cap |
|---|---|---|
| -1335.64% | $57.68M | |
| -177.32% | $2.81M | |
| -57.44% | $4.40M | |
| -69.57% | $10.81M | |
| -292.33% | $8.43M | |
| -631.47% | $2.33M | |
| -26.83% | $5.04M | |
| -165.94% | $5.52M | |
| -141.01% | $1.53M | |
| -246.04% | $4.43M |
Build a custom stock screener for AIM ImmunoTech Inc. (AIM) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AIM ImmunoTech Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
AIM ImmunoTech Inc. (AIM) and other stocks custom spreadsheet templates
The easiest way to analyze a company like AIM ImmunoTech Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is AIM ImmunoTech Inc.'s ROE?
How is the ROE calculated for AIM ImmunoTech Inc. (AIM)?
What is the highest ROE for AIM ImmunoTech Inc. (AIM)?
What is the 3-year average ROE for AIM ImmunoTech Inc. (AIM)?
What is the 5-year average ROE for AIM ImmunoTech Inc. (AIM)?
How does the current ROE for AIM ImmunoTech Inc. (AIM) compare to its historical average?